The global Epigenetic market is projected to reach US$ 11230 million by 2030.
Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence.
This report contains market size and forecasts of Epigenetic in Global, including the following market information:
Global Epigenetic Market Size 2025-2030, ($ millions)
The global market for epigenetic device market is expected to be driven by the advancement in technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epigenetic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epigenetic Market, by Type, 2025-2030 ($ millions)
Global Epigenetic Market Segment Percentages, by Type
Reagents
Kits
Instruments
Enzymes
Services
Global Epigenetic Market, by Application, 2025-2030 ($ millions)
Global Epigenetic Market Segment Percentages, by Application
Academic Research Institutes
Biotechnology Companies
Biopharmaceutical Companies
Diagnostic Companies
Global Epigenetic Market, By Region and Country, 2025-2030 ($ Millions)
Global Epigenetic Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Illumina
Qiagen
Abcam
Merck & Co
Sigma-Aldrich
New England Biolabs
Thermo Fisher Scientific
Diagenode
Active Motif
Roche Diagnostics
Eisai
Novartis
